STAT+: Seaport Therapeutics adds another $225 million to coffers to embrace the ‘golden age of neuroscience’
STAT
OCTOBER 20, 2024
Seaport Therapeutics, the startup launched earlier this year by the team behind Karuna Therapeutics, has raised another $225 million just six months after its most recent fundraising round. Seaport raised the Series B funds from General Atlantic, Foresite Capital, T. Rowe Price Associates, and other investors. The startup, which is based in Boston, is developing a new cohort of what executives hope will be faster-acting, more effective treatments for depression, anxiety, and other mental health
Let's personalize your content